National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel - Disclosures as of 8/15/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

J. Pablo Arnoletti, MD

OSI Pharmaceuticals, Inc.;
Merrimack Laboratories

None

None

None

5/3/2011

Stephen Behrman, MD

None

None

None

None

4/22/2013

Edgar Ben-Josef, MD

None

None

None

None

6/7/2011

Al B. Benson III, MD, FACP

None

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Eli Lilly and Company;
General Electric;
Genomic Health, Inc.;
National Cancer Institute;
Onyx Pharmaceuticals, Inc.

None

None

8/31/2012

Ephraim S. Casper, MD

None

None

None

None

8/16/2012

Steven J. Cohen, MD

None

None

None

None

9/17/2012

Brian Czito, MD

None

None

None

None

8/17/2012

Joshua D.I. Ellenhorn, MD

None

None

None

None

9/29/2009

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

William G. Hawkins, MD

None

None

None

None

9/14/2012

Joseph Herman, MD

None

None

None

None

4/12/2013

John P. Hoffman, MD

None

None

None

None

4/11/2013

Andrew H. Ko, MD

None

None

None

None

10/8/2012

Srinadh Komanduri, MD

None

None

None

None

10/9/2012

Albert Koong, MD, PhD

None

None

None

None

9/20/2012

Wen Wee Ma, MD

None

None

None

None

9/14/2012

Mokenge P. Malafa, MD, FACS

None

None

None

None

9/14/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nipun B. Merchant, MD

None

None

None

None

12/13/2011

Sean J. Mulvihill, MD

National Cancer Institute

None

None

None

9/14/2012

Peter Muscarella II, MD

GlobeImmune

None

None

None

9/11/2012

Eric K. Nakakura, MD

None

None

None

None

10/27/2011

Jorge Obando, MD

None

None

None

None

9/18/2012

Martha B. Pitman, MD

None

None

None

None

10/9/2012

Aaron R. Sasson, MD

None

None

None

None

10/8/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Anitra Talley

None

None

None

None

9/19/2012

Margaret A. Tempero, MD

None

Myriad Genetic Laboratories, Inc.;
Antisense Pharma;
Halozyme Therapeutics;
sanofi-aventis U.S.

None

None

7/11/2012

Sarah P. Thayer, MD, PhD

None

Lustgarten Foundation

None

None

9/20/2012

Samuel Whiting, MD, PhD

None

Genentech, Inc.

None

None

4/4/2012

Robert A. Wolff, MD

None

None

None

None

7/12/2012

Brian M. Wolpin, MD, MPH

None

None

None

None

7/11/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved